baber/WOPTO huggingface dataset:
Patent CA-2500520-A1 (CA)
Inventor: OHMER HERVE
IPC: E21B/
Filed: 2005-03-10
Abstract: The invention is a sealing system, such as a packer, that is used in a wellbore to seal against an exterior surface, such as a casing or open wellbore. The sealing system includes a swellable material that swells from an unexpanded state to an expanded state thereby creating a seal when the swellable material comes into contact with a triggering fluid.
Patent CA-2500770-A1 (CA)
Inventor: MCMANUS JEFFREY L
IPC: A61B19/02
Filed: 2003-07-10
Abstract: L'invention concerne une matière pour emballage de stérilisation en une étape servant, par exemple, à envelopper des instruments chirurgicaux et servant dans la stérilisation, le transport, et le stockage. Ledit emballage de stérilisation comprend une première feuille comprenant une matière non tissée, cette dernière présentant une majorité de fibres parallèles, ou sensiblement parallèles, à un côté de la feuille ; une seconde feuille comprenant une matière non tissée présentant une majorité de fibres parallèles ou sensiblement parallèles à un côté de la feuille. La seconde feuille est tournée et jointe à la première feuille sur un ou plusieurs points de liaison, de sorte que la majorité des fibres orientées dans la seconde feuille sont sensiblement orthogonales à la majorité des fibres orientées dans la première feuille.
Patent CA-2501552-A1 (CA)
Title: Substituted aminoquinuclidine compounds
Inventor: REITZ ALLEN B
IPC: C07D453/02
Filed: 2003-10-14
Abstract: This invention is directed towards substituted aminoquinuclidine compounds of Formula (I); (I) wherein: Ar is selected from the group consisting of aryl and heteroaryl; n is an integer from 0 to 2; useful as delta-opioid receptor modulators, delta-opioid receptor agonists useful as analgesics and delta-opioid receptor antagonists useful as immunosuppressants, antiinflammatory agents, agents for the treatment of neurological and psychiatric conditions, medicaments for drug and alcohol abuse, agents for treating gastritis and diarrhea, cardiovascular agents and agents for the treatment of respiratory diseases.
Patent CA-2509646-A1 (CA)
Inventor: SUAZO ISAAC
IPC: E02B13/00
Filed: 2003-04-09
Abstract: L'invention concerne un dispositif et un procédé destinés à la mise en place de revêtements dans des fossés (10), faisant intervenir une pluralité de sections de revêtement (12) sensiblement ondulées, fabriquées de préférence à partir d'un matériau thermoplastique, tel que le polyéthylène. Chaque section de revêtement est conçue pour être assemblée de manière amovible par ses extrémités opposées (14). Un matériau d'étanchéité (114) qui ne colle pas au matériau thermoplastique peut également être utilisé. Pour relier deux sections de revêtement, il suffit d'assembler par pression un premier segment de canal de blocage (26) et un second canal de blocage (28). Un canal d'entrée/sortie (116) peut être fixé par pression et de manière amovible à au moins une extrémité (14) d'une section de revêtement. Une section de revêtement sous forme de section de répartition (136) permet de réorienter le flux d'eau dans plusieurs directions, par un fossé équipé du présent dispositif. Le dispositif comprend également une section de dérivation (150) permettant de dévier l'eau s'écoulant dans une direction, vers un point ou une zone de distribution d'eau, ainsi qu'un adaptateur (162) pouvant être utilisé pour interconnecter des sections de revêtement (12) incompatibles.
Patent CA-2510999-A1 (CA)
Inventor: YACCATO KARIN
IPC: C01B32/40
Filed: 2003-12-18
Abstract: L'invention concerne un procédé et des catalyseurs destinés à la production d'un gaz de synthèse riche en hydrogène. Ce procédé consiste à mettre un gaz contenant du CO en contact avec un catalyseur de conversion en présence d'eau, de préférence à une température inférieure à 450· environ. L'invention concerne également un catalyseur de conversion préparé à partir a) du Pt, de ses oxydes ou de mélanges de ses oxydes, b) de Fe et/ou de Rh, de leurs oxydes ou de mélanges de leurs oxydes, c) d'au moins un élément sélectionné dans le groupe comprenant du Sc, du Y, du Ti, du Zr, du V, du Nb, du Ta, du Mo, du Re, du Co, du Ni, du Pd, du Ge, du Sn, du Sb, du La, du Ce, du Pr, du Nd, du Sm, et de l'Eu, leurs oxydes et des mélanges de leurs oxydes. Le catalyseur de conversion peut utilisé sur un support à base d'oxyde d'aluminium, d'oxyde de zirconium, d'oxyde de titane, d'oxyde de cérium, d'oxyde de magnésium, d'oxyde de lanthane, d'oxyde de niobium, d'oxyde d'yttrium et d'oxyde de fer ou de mélanges de ces oxydes. L'invention concerne également des dispositifs de traitement du carburant contenant ces catalyseurs de conversion.
Patent CA-2511919-A1 (CA)
Inventor: RAMASWAMY ARUN
IPC: H04L29/06
Filed: 2003-05-13
Abstract: A transcoder (22) is adapted to performed to transcoding of metadata to enable sharing and consumption of media content at dissimilar devices (12) that are coupled to a home network (10). The transcoder (22), which is also coupled to the home network (10), is adapted to receive media content and metadata from a first media consumption device (12), to transcode the media content and metadata from a first format to second format, and to supply the transcoded media content and metadata to the second media consumption device (12) in the second format.
Patent CA-2515168-A1 (CA)
Inventor: KOSTER RICHARD R
IPC: A63B53/04
Filed: 2005-08-04
Abstract: The present invention provides an improved putter and putter training device or aid that assists a golfer in improving their putting stroke. In one embodiment of the invention a putter is provided featuring a putter head having a front surface and a rear surface, and at least one guide displaceable relative to the front surface from a first position wherein the guide extends forward of the front surface to a second position wherein the front surface of the putter head is unobstructed by the guide. In one embodiment the guide is displaceable through a bore provided in the putter head. In a further embodiment of the invention the guide is rotatably displaceable in relation to the putter head. In another embodiment of the invention, a putter incorporating features of the invention is illustrated, the putter comprising a putter head having a front surface and a rear surface, two guides extending from the front surface, and two guides extending from the rear surface. In a further aspect of the invention a putter training device or aid is provided. The putter training aid comprises a substantially planar body having two faces, one of the faces featuring a fastener to releasably secure the putter training aid to a putter head.
Patent CA-2517920-A1 (CA)
Title: Method for producing ethanol using raw starch
Inventor: LEWIS STEVEN M
IPC: A23L21/25
Filed: 2004-03-10
Abstract: The present invention relates to methods for producing high levels of alcohol during fermentation of plant material, and to the high alcohol beer produced.  The present invention also relates to methods for producing high protein distiller's dried grain from fermentation of plant material, and to the high protein distiller's dried grain produced. The present invention further relates to reduced stack emissions from drying distillation products from the production of ethanol.
Patent CA-2520896-A1 (CA)
Title: Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
Inventor: NARJES FRANK
IPC: C07D401/14
Filed: 2004-04-02
Abstract: The present invention relates to indole and azaindole compounds of formula (I): wherein X1, X2, X3, X4, A1, Ar1, R1, R2 and n are as defined herein, and pharmaceutically acceptable salts thereof, useful in the prevention and treatment of hepatitis C infections.
Patent CA-2523329-A1 (CA)
Title: Resin composition for use in a froth spraying system
Inventor: JANZEN CHRIS
IPC: C08L75/12
Filed: 2005-10-12
Abstract: A resin composition for use in a froth spraying system for forming polyurethane foam is disclosed. The resin composition comprises a Mannich polyol, at least one additional polyol other than a Mannich polyol, and a physical blowing agent. The Mannich polyol has a viscosity of at least 4,000 centipoise at 25 °C. The physical blowing agent is selected from the group of volatile non-halogenated C2 to C7 hydrocarbons, hydrofluoro-carbons, hydrochlorocarbons, and mixtures thereof. The physical blowing agent is present in an amount of greater than 10 parts by weight based on 100 parts by weight of the resin composition. A method of forming the polyurethane foam is also provided comprising the steps of providing the resin composition and a polyisocyanate, mixing the resin composition with the polyisocyanate in a mixing chamber to form a mixture, and discharging the mixture from a dispensing gun as the resin composition reacts with the polyisocyanate to form the polyurethane foam.
Patent CA-2523936-A1 (CA)
Inventor: ROY ANDRE
IPC: B28B1/14
Filed: 2005-10-20
Abstract: a system for filling molds with cementitious concrete-like material and for unmolding resulting products, the system is comprised of an unmolding and molding subsystem. This subsystem iscomprised of a mold unstacking station, an unmolding station, a mold preprocessing station, a concrete pouring station, a concrete leveling station and a mold stacking station. The system is also comprised of a concrete curing station and a concrete batching station.
Patent CA-2531528-A1 (CA)
Inventor: SCHWAMMENTHAL EHUD
IPC: A61F2/86
Filed: 2004-07-06
Abstract: Prosthetic devices as described for use in the treatment of aortic stenosis in the aortic valve of a patient's heart, the prosthetic device having a compressed state for transarterial delivery and being expandable to an expanded state for implantation. The prosthetic device includes an expandable metal base (10) constructed so as to be implantable in the expanded state of the prosthetic device in the aortic annulus of the aortic valve; and an inner envelope lining (11) tune inner surface of the metal base (10). The inner envelope, in the expanded state of the prosthetic device, extends into the aorta and is of a diverging conical configuration, in which its diameter gradually increases from its proximal end within the aortic annulus to its distal end extending into the aorta, such as to produce, during systole, a non-turbulent blood flow into the aorta with pressure recovery at the distal end of the inner envelope. Preferably, the distal end includes a prosthetic valve which is also concurrently implanted, but such a prosthetic valve may be implanted separately in the aorta. Also described are preferred methods of implanting such prosthetic devices.
Patent CA-2533375-A1 (CA)
Inventor: IMAMURA HIDEAKI
IPC: C07H19/23
Filed: 2004-07-21
Abstract: Crystalline 6-N-pyridylmethylamino-12,13-dihydro-2,10 -dihydroxy-12-.beta.-D-glucopyranosyl-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-diones in the form of the free bases as represented by the general formula (I), pharmaceutically acceptable salts of the same, or solvates thereof: (I) wherein R is unsubstituted or hydroxymethylated pyridylmethyl.
Patent CA-2533784-A1 (CA)
Title: Glycoside having 4-methylergost-7-en-3-ol skeleton and hyperglycemia improving agent
Inventor: TANAKA MIYUKI
IPC: A61K31/704
Filed: 2005-03-30
Abstract: 3-0-.beta.-D-Glucopyranosyl-4-methylergost-7-en-3-ol or a composition containing 0.001% by mass or more of the aforementioned compound, which is an extract of a plant of the family Liliaceae containing the compound or a fraction thereof, is used as an active ingredient of a hyperglycemia improving agent.
Patent CA-2534342-A1 (CA)
Inventor: CHANDRAN V RAVI
IPC: C07D257/04
Filed: 2004-07-29
Abstract: The present invention is directed to a prodrug comprised of an amino acid bonded to a medicament or drug having a hydroxy, amino, carboxy or acylating derivative thereon. The prodrug has the same utility as the drug from which it is made, but it has enhanced therapeutic properties. In fact, the prodrugs of the present invention enhance at least two therapeutic qualities, as defined herein. The present invention is also directed to pharmaceutical compositions containing same.
Patent CA-2537107-A1 (CA)
Inventor: STEWART DAVID B
IPC: H02K7/18
Filed: 2005-03-15
Abstract: A linear electric generator (LEG) includes sections of coils of an induction coil assembly (ICA) disposed along a distance d1 and apparatus for passing a per anent magnetic assembly (PMA) of length d2, where d2 is less than d1, along the coils for generating voltages and power in the coils in close proximity to the PMA. Unidirectional conducting elements are connected between the coils and output power lines to couple the voltages developed across excited coils to the output power lines without the unexcited coils loading down or dissipating the volts e developed across the output power lines.
Patent CA-2537820-A1 (CA)
Title: Process for preparing water-soluble medicaments comprising complexation of forskolin in cyclodextrins
Inventor: MAJEED MUHAMMED
IPC: A01N65/00
Filed: 2004-09-02
Abstract: Aqueous solutions of diterpenes such as Forskolin, its congeners, analogs and derivatives, up to approximately 6% concentration, are prepared using suitably substituted cyclodextrin as a solubilizing agents. In the absence of cyclodextrin, some diterpenes such as Forskolin are soluble in water only to concentrations of about 0.001 % .Such aqueous solutions find applications in topical and systemic use, as pharmaceutical, cosmeceutical, nutraceutical preparations containing diterpenes such as Forskolin and congeners.
Patent CA-2538015-A1 (CA)
Inventor: MAEKELAE RAIMO ANTERO
IPC: H03L7/099
Filed: 2003-09-05
Abstract: A method to control a frequency oscillator, as a crystal oscillator, and to form an oscillating circuit in order to produce a frequency oscillator improved to its qualities, in which the frequency of reference oscillator (1) is changed by means of frequency multiplier (2) into output frequency. As frequency oscillator a low frequency oscillator (1) is used, the control of which output frequency (5) is carried out adjusting the low frequency oscillator (1) by means of control arrangement (4).
Patent CA-2538613-A1 (CA)
Title: A method for identifying user position
Inventor: WU HAIJUN
IPC: H04L12/56
Filed: 2004-09-07
Abstract: The present invention provides a method for identifying user position. By adding two tags i.e. a VlanCI tag and a VlanPI tag for identifying users accessed into broadband access network, the number of users accessing to the broadband access network is increased, and the problem of having insufficient VLAN ID in the broadband access network is solved, so that the broadband access network can hold any number of users. By using this invention, devices in the broadband access network only need to do VlanPI scheduling during the message transmission, without caring about the details of user services, i.e. devices in the broadband access network carry out the management in thick path manner rather than in thin path manner, and the features associated with user services are solved by the cooperation of broadband access devices and BAS devices. Additionally, private tag information in the internal network of users is transferred transparently through the whole network, and the device in the broadband access network will not perform any processing on this information.
Patent CA-2539458-A1 (CA)
Inventor: BRAITHWAITE MICHAEL
IPC: H04R5/04
Filed: 2006-03-14
Abstract: An integrally mounted control point node for use in an audio distribution system and including a control processor for receiving command signals and providing audio control signals to response thereto; a command signal generator for producing the command signals in response to activation by a user of the system; a terminal for receiving a plurality of audio signals; an audio signal tuner for receiving the control signals and the audio signals; an amplifier receiving an output signal from the tuner and the control signals from the control processor; and a speaker terminal for transmitting the output signal to a speaker.
Patent CA-2539618-A1 (CA)
Inventor: SUMAKERIS JOSEPH JOHN
IPC: H01L21/205
Filed: 2004-09-14
Abstract: A method is disclosed for preparing a substrate and epilayer for reducing stacking fault nucleation and reducing forward voltage (Vf) drift in silicon carbide-based bipolar devices. The method includes the steps of etching the surface of a silicon carbide substrate with a nonselective etch to remove both surface and subsurface damage, thereafter etching the same surface with a selective etch to thereby develop etch-generated structures from at least any basal plane dislocation reaching the substrate surface that will thereafter tend to either terminate or propagate as threading defects during subsequent epilayer growth on the substrate surface, and thereafter growing a first epitaxial layer of silicon carbide on the twice-etched surface.
Patent CA-2540276-A1 (CA)
Inventor: CRAGO WILLIAM BARRY
IPC: H04L12/26
Filed: 2006-03-20
Abstract: A method of populating a location information database for use in providing a location-based service to a host device that is an endpoint of a logical connection between the host device and a network access server. The method comprises receiving from the host device over the logical connection a request for network access; assigning a logical identifier to the host device in response to the receiving; determining a physical location associated with the endpoint of the logical connection; creating an association between the logical identifier and the physical location; and storing the association in the location information database.
Patent CA-2540658-A1 (CA)
Title: Operating systems
Inventor: GROUZDEV VLADIMIR
IPC: G06F9/40
Filed: 2004-10-01
Abstract: A method of enabling multiple different operating systems to run concurrently on the same RISC computer, comprising selecting a first operating system to have a relatively high priority (the realtime operating system, such as C5);  selecting at least one secondary operating system to have a relatively lower priority (the general purpose operating system, such as Linux); providing a common program (a hardware resource dispatcher similar to a nanokernel) arranged to switch between said operating systems under predetermined conditions; and providing modifications to said first and second operating systems to allow them to be controlled by said common program.
Patent CA-2540961-A1 (CA)
Title: Absorbent article comprising an absorbent structure
Inventor: VARTIAINEN KENT
IPC: A61F13/15
Filed: 2004-10-04
Abstract: The invention relates to an absorbent article such as a diaper, an incontinence pad, a sanitary towel or the like, the article having a liquid-permeable upper surface and comprising an absorbent structure which comprises at least a first superabsorbent material and a second superabsorbent material.  The first superabsorbent material is characterized in that it is an odour-inhibiting and/or bacteria-inhibiting superabsorbent material, and in that it has a higher absorption rate than the second superabsorbent material.
Patent CA-2542586-A1 (CA)
Inventor: WHITE MICHAEL DAVID EDWARDS
IPC: F42B39/30
Filed: 2004-09-17
Abstract: A detonator assembly (30A) includes first and second cable coils (90, 92) a detonator (116) which is connected to one end of the first cable coil (90), a first connector (110) which connects an opposing end of the first cable coil (90) to one end of the second cable coil (92), a second connector (114) which is connected to an opposing end of the second cable coil (92), and confinement structure around the first and second cable coils (90, 92).
Patent CA-2544781-A1 (CA)
Inventor: KAMIYAMA TOMONORI
IPC: A61P3/04
Filed: 2004-11-04
Abstract: [MEANS FOR SOLVING PROBLEMS] A lotus leaf extract is prepared and it is found out that quercetin is one of the active components thereof. Effects of quercetin are evaluated by treating a cell expressing human .beta.3-adrenoceptor and a diabetic model mouse with it. As a result, it is found out that quercetin acts as a .beta.3-adrenoceptor agonist and thus exerts an effect of ameliorating obesity and an atidiabetic effect in practice.
Patent CA-2545428-A1 (CA)
Inventor: DENIS MARTIN
IPC: G06F9/46
Filed: 2006-05-01
Abstract: A memory, system and method for task scheduling and execution, the memory containing a data structure including a scheduling file containing tasks scheduled for execution, and a cancelling file containing references to tasks which execution is cancelled. A scheduler module reads the scheduled tasks of the scheduling file and the cancelled tasks of the cancelling file, and triggers execution of the scheduled tasks not referenced in the cancelling file. The data structure may comprise a plurality of pairs of scheduling and cancelling files, each pair being associated with a time interval. When the scheduler module receives from an application module a task scheduling request for scheduling a task, it writes the task in the task scheduling file. When the scheduler module further receives a task cancelling request for cancelling of the task, it writes the task in the task cancelling file.
Patent CA-2548273-A1 (CA)
Inventor: SOMERS MARIA VICTORINA FRANCIS
IPC: A61K31/498
Filed: 2004-11-18
Abstract: The present invention provides compounds of formula (I), their use as PARP  inhibitors as well as pharmaceutical compositions comprising said compounds of formula (I) wherein n, s, R1, R2, R3, Q, X and Y have defined meanings.
Patent CA-2548448-A1 (CA)
Title: Novel 2-hydroxytetrahydrofurane derivatives and use thereof as medicaments
Inventor: CHABRIER DE LASSAUNIERE PIERRE
IPC: C07K5/078
Filed: 2004-12-08
Abstract: 3-Amino-2-hydroxytetrahydrofuran derivatives (I), N-substituted by a di- or tripeptide side-chain terminated by a dibenzazepine, phenoxazine, phenothiazine or phenazine group, are new. Tetrahydrofuran derivatives of formula (I) and their salts are new. [Image] A : a tricyclic group of formula (i); R 1>, R 2>, R 4>-R 6>H, halo, OH, alkyl, alkoxy, CN, NO 2or NR 7>R 8>; R 7>, R 8>H, alkyl or COR 9>; R 9>H, alkyl or alkoxy; R 3>H, alkyl or COR 10>; R 10>H, alkyl or alkoxy; W : CH 2CH 2, CH=CH, O, S or NR 11>; R 11>H or alkyl; X : CO, Y-CO, O-Y-CO or NR 12>-Y-CO; Y : alkylene or haloalkylene; R 12>H, alkyl or COR 9>; R 13>H, alkyl, haloalkyl or alkoxy; AA : a natural aminoacid (optionally having chemically reactive side-chain functions protected, specifically as (ar)alkyl ester for carboxy, as (ar)alkyl carbamate or (ar)alkyl carboxamide for amino or as (ar)alkyl (thio)ether or (ar)alkyl ester for alcohol or thiol) or NR 14>-(CH 2) p-CR 15>R 16>-CO, or (AA) 2may also be a carbapeptide of formula NR 17>-(CH 2) 3-CHR 18>-CO; p : 0 or 1; R 14>, R 15>, R 17>, R 18>H or alkyl; R 16>H, alkyl, haloalkyl, phenyl, cycloalkyl, cycloalkylalkyl or alkenyl, or CR 15>R 16>3-7C (preferably 3-6C) cycloalkylidene; n : 2 or 3; R : H, alkyl or COR 19>, and R 19>alkyl. [Image] ACTIVITY : Antiinflammatory, Immunosuppressive; Cardiant; Vasotropic; Cerebroprotective; Neuroprotective; Osteopathic; ophthalmological; virucide; antirheumatic; antiarthritic; antiulcerative; hypotensive; antibacterial; hemostatic; thrombolytic; anticoagulant; vulnerary; anticonvulsant; nootropic; antiparkinsonian; auditory; antiarteriosclerotic; dermatological; anti-HIV; antiparasitic; antidiabetic; cytostatic. MECHANISM OF ACTION : Calpain inhibitor; Lipid peroxidation inhibitor. In a test, N-(10H-phenothiazin-2-ylcarbonyl)-L-leucyl-L-leucyl-N 1>-((3S)-2-hydroxytetrahydrofuran-3-yl)-L-leucinamide (Ia) exhibited an IC 50value of less than 5 mu M for inhibition of human calpain I.